Blood test may reveal how well pancreatic cancer treatment works

NCT ID NCT04616131

First seen Jun 19, 2026 · Last updated Jun 23, 2026 · Updated 1 time

Summary

This study is looking at whether a blood test can detect tiny bits of pancreatic cancer DNA in patients before, during, and after chemotherapy. Researchers hope this could help predict how well the treatment is working. The study involves 500 adults with pancreatic cancer that has not spread to other organs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Northwestern Medicine Cancer Center Delnor

    RECRUITING

    Geneva, Illinois, 60135, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Northwestern Medicine Cancer Center Kishwaukee

    RECRUITING

    DeKalb, Illinois, 60115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Northwestern Medicine Cancer Center Warrenville

    RECRUITING

    Warrenville, Illinois, 60555, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test to monitor how well pancreatic cancer treatment is working.

What could go wrong

This is an observational study, not a treatment trial. It may not find a clear link between ctDNA levels and patient outcomes.

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.